Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
A fibula free flap can be used for the reconstruction of a mandible or a maxillar when the lack of bonne exceeds 3cm. This flap is made of the fibula bone, some muscle around, the fibular vascular pedicle and a skin paddle to reconstruct the gum. Once this flap has been taken and transposed on the face, the leg is closed with a split thickness skin graft to replace the skin paddle. But the healing on this site is often a problem: this is partly due to the high rate of early graft's loss due to local devascularization (3 to 55% of loss). The skin grafting is generally improved by the application of a dressing sewn and left in place during 5 to 7 days postoperative (standard method). This study will evaluate the efficiency of a portative miniature negative pressure dressing system named PICO® on the split-thickness skin graft of fibula free flap donor sites, compared to the standard method. A prospective randomized evaluation will be done, comparing the PICO® to a conventional dressing. The main aim of the study is the evaluation of the impact of this portative system on the healing of the skin grafted donor site, in terms of rate of skin take, time of healing, complications and medical costs. The patients will be seen preoperatively to decide on their inclusion in the protocol. They will be reviewed at day 10 to evaluate the engraftment and possible local complications on the donor site. They will then be reviewed at day 20 and day 30 and until complete healing. The follow up will be of 12 months maximum. A medical cost evaluation will be done comparing the costs generated by the care on the donor site in the 2 groups.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Contraindication to making a fibula free flap:
Contraindication to the setting up of a negative pressure therapy:
No affiliation to a social security scheme.
Minor or major patients who are protected or unable to give their consent (according to article L1121-8 of the Public Health Code (PHC))
Pregnant or lactating women (according to article L1121-5 of the PHC)
Vulnerable people (according to article L1121-6 of the PHC)
Primary purpose
Allocation
Interventional model
Masking
112 participants in 2 patient groups
Loading...
Central trial contact
Marie De Boutray, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal